| Financial Year |
March 31 2023 |
| Monetary Funds |
377,515,126.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
255,277,019.39 |
| Advances to Suppliers |
46,780,522.00 |
| Other Receivables |
6,978,365.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
488,096,060.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,906,659.72 |
| Other Current Assets |
76,037,320.94 |
| Total Current Assets |
1,261,591,073.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,777,397,076.61 |
| Under-construction Projects |
244,386,808.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
155,105,557.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
341,811.60 |
| Deferred Income Tax Assets |
93,730,255.34 |
| Other Non-Current Assets |
43,789,291.65 |
| Sub-Total of Non-Current Assets |
2,315,044,200.49 |
| Total Assets |
3,576,635,274.38 |
| Short-Term Loans |
738,761,844.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
202,751,900.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,577,828.59 |
| Taxes Payable |
17,266,758.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,559,162.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,082,888.86 |
| Other Current Liabilities |
7,886,635.76 |
| Sub-Total of Current Liabilities |
1,073,316,135.97 |
| Long-term Loans |
114,378,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
42,310,814.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
191,689,296.53 |
| Total Liabilities |
1,265,005,432.50 |
| Paid-In Capital(Or Share Stock) |
1,233,696,500.00 |
| Capital Surplus |
452,881,672.97 |
| Surplus Reserve |
175,504,661.10 |
| LESS:Treasury Stock |
475,137,439.61 |
| Undistributed Profits |
908,854,957.19 |
| Minority Stockholder's Interest |
15,829,490.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,295,800,351.65 |
| Owner's Equity（Stockholder's Equity） |
2,311,629,841.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,576,635,274.38 |
